Pulsed electromagnetic field therapy

Electricity Holds Key to Chronic and Prescription-Resistant Pain, Experts Say

Retrieved on: 
Thursday, June 30, 2022
Athlete, Electromagnetic field, Ageing, Patient, Pulsed electromagnetic field therapy, Research, Author, Health survival paradox, Chronic pain, Radio, The New York Times, Pain, Survival, The Dr. Oz Show, DNA, Summit, Amnesia, Electricity, Injury, CDC, Medical device, PEMF

CARLSBAD, Calif., June 30, 2022 /PRNewswire/ -- Join DrTalks.com and the foremost authority in North America for PEMF therapy, Dr. William Pawluk, from Tuesday, July 12th to Wednesday, July 20th, for the Pulsed Electromagnetic Field (PEMF) Healing Summit, a free 7-day virtual event exploring the physical and mental benefits of PEMF therapy. Dr. Pawluk is joined at the summit by his co-hosts, Dr. Marlene Mahipat and Dr. Riz Lakhani. Featured speakers include Dr. Isaac Eliaz (Author of The Survival Paradox), Kashif Khan (founder of The DNA Company), and Dr. Joel Fuhrman (7-time New York Times bestselling author).

Key Points: 
  • Dr. Pawluk is joined at the summit by his co-hosts, Dr. Marlene Mahipat and Dr. Riz Lakhani.
  • Experts believe PEMF therapy might be the future of chronic pain treatment.
  • At the Pulsed Electromagnetic Field (PEMF) Summit, 40+ world-renowned experts (including doctors, researchers, scientists, authors, and more) will examine the research behind PEMFs.
  • He has 30+ years of experience in PEMF therapy and is committed to providing safe and effective treatment to his patients with chronic pain.

Publication of Data Shows High Fusion Rate in Patients Treated with PEMF Therapy Using the Orthofix SpinalStim Device

Retrieved on: 
Monday, July 12, 2021
Biotechnology, FDA, Other Health, Diabetes, Health, Other Science, Medical devices, Research, Hospitals, Surgery, Science, Medical specialties, Clinical medicine, Surgery, Spinal fusion, Pulsed electromagnetic field therapy, Neurosurgery, Thomas Schuler, Failed back syndrome, the SpinalStim Bone Growth Therapy Device, Orthofix, THE SPINALSTIM BONE GROWTH THERAPY DEVICE, ORTHOFIX

(NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the publication of retrospective data evaluating fusion rates in patients receiving three- and four-level lumbar arthrodesis surgery who were treated adjunctively with the SpinalStim bone growth therapy device.

Key Points: 
  • (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the publication of retrospective data evaluating fusion rates in patients receiving three- and four-level lumbar arthrodesis surgery who were treated adjunctively with the SpinalStim bone growth therapy device.
  • View the full release here: https://www.businesswire.com/news/home/20210712005147/en/
    Illustration of the Orthofix SpinalStim Bone Growth Therapy device for patients recovering from lumbar fusion surgery.
  • The fusion rate was very good across all patient types including those who were potentially at high risk of fusion failure.
  • These results reconfirm the benefit PEMF therapy can provide patients when used after multi-level lumbar fusion surgery.

Stanford University Orthopedic Study Collaboration with Endonovo Therapeutics SofPulse® Devices Moves Forward

Retrieved on: 
Tuesday, May 11, 2021
Medicine, Clinical medicine, Health care, Orthopedic surgery, XC2, Pulsed electromagnetic field therapy

b'Los Angeles, CA, May 11, 2021 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced completion of Shipment of SofPulse\xc2\xae tPEMF Devices for use in a Stanford University sponsored Orthopedic Shoulder and Knee Study.

Key Points: 
  • b'Los Angeles, CA, May 11, 2021 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced completion of Shipment of SofPulse\xc2\xae tPEMF Devices for use in a Stanford University sponsored Orthopedic Shoulder and Knee Study.
  • The Stanford Orthopedic study titled, \xe2\x80\x98Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery\xe2\x80\x99 is scheduled for a final completion date of August 2022.
  • Endonovo CEO, Alan Collier, States, \xe2\x80\x9cOur Executive team at Endonovo are elated to continue our collaboration with Stanford University in Palo Alto, CA and are encouraged that the Stanford Orthopedic study is continuing to advance and is on track to meet posted study deadlines.
  • Collier continues, \xe2\x80\x9cWe believe this is a unique opportunity for SofPulse\xc2\xae devices to be evaluated by Stanford University\xe2\x80\x99s Orthopedic division.

BioElectronics Earns CE Mark for the ActiPatch and RecoveryRx -- Drug-Free Pain Therapy Devices

Retrieved on: 
Thursday, November 12, 2020
Branches of biology, Pain, Human back, Nervous system, Acute pain, Pain management, Palliative care, Back pain, Pulsed electromagnetic field therapy

The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue pain, while the RecoveryRx is indicated for the treatment of postoperative pain.

Key Points: 
  • The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue pain, while the RecoveryRx is indicated for the treatment of postoperative pain.
  • These wearable devices can now be sold over the counter in 33 European Union (EU) countries, and many other non-EU countries like Australia that recognize the CE mark.
  • The CE mark will allow us to resume fulfilling substantial orders for existing international partners, and close pending deals that were contingent on the CE mark.
  • BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx Therapy for postoperative pain and chronic wound care.

NeoRhythm, the world's first gesture-controlled headband proven effective for neurostimulation, is now the focus of the most comprehensive scientific research in history

Retrieved on: 
Tuesday, October 13, 2020
Branches of biology, Electrotherapy, Neurotechnology, Pain management, Pulsed electromagnetic field therapy, Medicine, Indiegogo, Brain, Health care

With a modest target of $25,000 for their NeoRhythm PEMF headband device, they wound up with a viral success on IndieGoGo, raising $1.7 million.

Key Points: 
  • With a modest target of $25,000 for their NeoRhythm PEMF headband device, they wound up with a viral success on IndieGoGo, raising $1.7 million.
  • Since the launch in 2019, the company has now sold over 8000 units worldwide, gathering the customers' feedback to conclude the largest PEMF research to date.
  • The brain can thus be compelled to go into various modes based on brain wave patterns that the pulses mimic.
  • The scale of the research part of the project is unprecedented, with more than 1500 PEMF users participating.

Ark Restaurants Announces Conference Call

Retrieved on: 
Thursday, June 18, 2020
Retail, Restaurant, Bar, Food, Beverage, Branches of biology, Articles, Medicine, Stem cells, Electrotherapy, Neurotechnology, Pain management, Pulsed electromagnetic field therapy, Therapy, Stem-cell therapy, Vitamin C, Cell therapy

Ark Restaurants Corp. (NASDAQ:ARKR) will hold a conference call for investors and analysts to discuss financial results for the second quarter ended March 28, 2020 on Tuesday, June 23, 2020 at 2:00 p.m. Eastern Time.

Key Points: 
  • Ark Restaurants Corp. (NASDAQ:ARKR) will hold a conference call for investors and analysts to discuss financial results for the second quarter ended March 28, 2020 on Tuesday, June 23, 2020 at 2:00 p.m. Eastern Time.
  • The dial-in numbers to participate in the conference call are:
    The Company will also broadcast its conference call over the Internet.
  • A replay of the broadcast will be available within one hour of the call, and will be available for 72 hours.
  • The dial-in telephone numbers for the replay are:
    Ark Restaurants owns and operates 20 restaurants and bars, 17 fast food concepts and catering operations primarily in New York City, Florida, Washington, D.C, Las Vegas, NV and the gulf coast of Alabama.

New FTC COVID-19 warning letters take total to 250

Retrieved on: 
Thursday, June 18, 2020
Health sciences, Health, Articles, Animal virology, Electrotherapy, Neurotechnology, Pain management, Pulsed electromagnetic field therapy, Coronavirus, Antiviral drug, Therapy, Coronaviridae

New FTC COVID-19 warning letters take total to 250Who got the latest letters and what representations raised concerns?

Key Points: 

New FTC COVID-19 warning letters take total to 250

    • Who got the latest letters and what representations raised concerns?
    • Arlington Integrative Medical Center.The Texas clinic advertised on its website (and in ALL CAPS): PROTECT YOUR FAMILY FROM CORONAVIRUS!
    • JUST A 30 MIN TREATMENT CAN KEEP YOUR IMMUNITY STRONG FOR UP TO 30 DAYS ONLY $150!!
    • On a webpage titled Coronavirus Tips COVID-19, the Montana business promoted a variety of products it sold as purported anti-virals, including elderberry, umcka, oregacillin, and licorice.
    • PEMF is an incredible drug-free technology that is currently one of the best ways to help prevent the virus from getting fatal.
    • Online and in social media, the California company promoted its CBD products by stating Have you heard the great news?!?!?!
    • CBD is being researched as a possible preventative and active treatment for COVID-19.
    • The clinic advertised its stem cell therapy with the claim, Best way to protect yourself from COVID-19 is to boost your immune system .
    • 1 Vial of Biogenix Stem Cells will modulate your immune system to ward off corona virus.
    • On its website, the company claimed coconut oil may protect you from coronavirus COVID-19, and included affiliate links to a variety of products.
    • It further claimed the Vitamin cocktail has had multiple randomized clinical trials revealing lower mortality and decreased hospitalization stay.
    • Based in Maryland, Dr. Pawluk recommended PEMF devices he sold as options for helping with COVID-19 prevention and treatment.
    • In marketing materials titled 4 Ways to Boost Your Immune System Amid Coronavirus, the Atlanta office linked to products it sold.
    • It also advertised its high dose Vitamin C IV Therapy as a way to Fight the Virus.
    • In response to the question on its website, So what can I do to protect myself against coronavirus today?

HealthyLine Wins Patent Infringement Dispute Protecting Customers from Imitators on Amazon

Retrieved on: 
Friday, June 5, 2020
Health, Pain management, Medicine, Electrotherapy, Neurotechnology, Pulsed electromagnetic field therapy, Therapy, Heat therapy, Patent, Infrared, Amazon

NEW YORK, June 5, 2020 /PRNewswire-PRWeb/ --HealthyLine, the world's leading provider of far infrared heat therapy mats made with natural hot stones, recently won a patent infringement dispute filed through Amazon's Neutral Patent Evaluation Program.

Key Points: 
  • NEW YORK, June 5, 2020 /PRNewswire-PRWeb/ --HealthyLine, the world's leading provider of far infrared heat therapy mats made with natural hot stones, recently won a patent infringement dispute filed through Amazon's Neutral Patent Evaluation Program.
  • The outcome allows HealthyLine to protect its U.S. patent for any infrared natural hot stone therapeutic mats that use pulsed electromagnetic field (PEMF) therapy, safeguarding consumers from ineffective and even harmful imitators.
  • Manufacturers and resellers that infringed upon HealthyLine's patent are now suspended by Amazon for all related listings with serious consequences for infringer's businesses.
  • This action ensures that consumers are only provided with effective and beneficial heat therapy mat options while shopping on Amazon.

Research Published in The Journal of the American Medical Association (JAMA) Shows Knee Osteoarthritis Patients Treated with AposTherapy® Experienced Significant Pain Reduction

Retrieved on: 
Monday, May 18, 2020
Medicine, Medical specialties, RTT, Skeletal disorders, Clinical medicine, Osteoarthritis, Arthritis, Pain management, Pulsed electromagnetic field therapy, Clinical trials on glucosamine and chondroitin

The patients included in the study were randomized to either AposTherapy or a similar looking control device.

Key Points: 
  • The patients included in the study were randomized to either AposTherapy or a similar looking control device.
  • The study demonstrated that AposTherapy significantly reduced pain associated with knee osteoarthritis, while also improving patients' physical function and stiffness.
  • AposTherapy is an innovative, FDA-cleared, temporary treatment for knee osteoarthritis, while qualifying as a non FDA-cleared wellness device for use with other musculoskeletal conditions such as low back pain.
  • By improving body mechanics and muscular coordination, AposTherapy has shown in clinical research that patients can achieve significant pain relief as well as an improvement in their daily physical function.

Endonovo Therapeutics Announces Eight Additional Hospitals Approved Use of SofPulse® at Their Facilities

Retrieved on: 
Thursday, April 16, 2020
Health, Articles, Electrotherapy, Neurotechnology, Pain management, Pulsed electromagnetic field therapy, Therapy, Hospital, Bioelectromagnetic medicine

Los Angeles, CA, April 16, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the addition of eight new hospitals Endonovos SofPulse medical device is approved for use.

Key Points: 
  • Los Angeles, CA, April 16, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the addition of eight new hospitals Endonovos SofPulse medical device is approved for use.
  • The eight hospitals are located in the following geographic areas: 7 Hospitals in Nevada and 1 Hospital in North Carolina.
  • The SofPulse PEMF (Pulsed Electromagnetic Frequency) therapy is non-invasive and non-pharmacologic with no known side effects and no potential for overdose or dependency.
  • SofPulse has been proven in clinical studies and in current hospital use to reduce pain and edema postoperatively while improving recovery in patients using the SofPulse device.